FKBP5 and Cowden syndrome 1: If validated, an FKBP5 mRNA assay could supplement or, in some cases, replace current diagnostic methods, such as the UFC, LNSC, or DST and could potentially supplement the current method of evaluating therapeutic efficacy based on the resolution of CS signs and symptoms.